NAD+ injections are not FDA-approved
User experience patterns after discontinuation Real-world user reports create clearer picture of post-GHK-Cu expectations than theoretical mechanism analysis, though anecdotal evidence requires careful interpretation recognizing placebo effects, confirmation bias, natural skin variation, lifestyle changes, and individual biological differences creating highly variable outcomes that don't necessarily predict individual experiences
After your skin has adjusted to the initial concentration without any adverse reactions, you can consider gradually moving to products with a higher concentration of GHK-Cu if you feel your skin can tolerate it
BPC-157 acts as a powerful mediator of the organoprotective response, orchestrating complex biological processes required for tissue repair and homeostasis
Multiple clinical studies have demonstrated an altered microbiome (dysbiosis) in PD
In daily life, that difference translates into more consistent mood, energy, and libido between doses